Details of the Drug Combinations

General Information of This Drug (ID: DMCM239)

Drug Name

Larotaxel DMCM239

Synonyms

Benzenepropanoic acid; PNU 100940; XRP 9881; XRP9881

Indication

Disease Entry	ICD 11	Status	REF
Bladder cancer	2C94	Discontinued in Phase 3	[1]
Pancreatic cancer	2C10	Discontinued in Phase 3	[1]
------------------------------------------------------------------------------------

Drug Type

Small molecular drug

Structure

3D MOL

2D MOL

List of Combinatorial Drugs (CBD) Containing This Drug

1 Clinical Trial Drug Combination(s) Consisting of This drug

DrugCom Name	DrugCom ID	Component Drug	Indication	REF
Larotaxel + Capecitabine	DCAI3TM	Capecitabine	Breast Cancer	[2]
------------------------------------------------------------------------------------

References

1	Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800010227)
2	ClinicalTrials.gov (NCT00327743) Combination Study of a New Taxane and Capecitabine in Patients With Metastatic Breast Cancer